Other News To Note
Tuesday, February 1, 2011
Pfizer Inc., of New York, completed its tender offer for Bristol, Tenn.-based King Pharmaceuticals Inc. The firms agreed to an acquisition deal in October that valued King at $14.25 per share, or about $3.6 billion.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.